Clindamycin Chew Treat
Clindamycin is a compounded formulation containing Clindamycin, prepared by Mixlab for veterinary use. Available by prescription.
Chew treats are flavored, soft treats that contain your pet’s medication—making giving meds as easy as offering a snack!
Use as directed by your veterinarian.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Clindamycin is a lincosamide antibiotic utilized extensively in veterinary medicine for the management of various bacterial challenges. It is a prescription medication available for use in dogs and cats, frequently considered by veterinarians for its activity against gram-positive and anaerobic organisms. Veterinarians most commonly consider clindamycin for patients presented with periodontal disease, deep-seated skin infections or localized tissue challenges like osteomyelitis (bone infection). It is also frequently a point of discussion for managing protozoal challenges such as toxoplasmosis or neosporosis. By inhibiting the protein production centers of susceptible bacteria and protozoa, your veterinarian can manage the progression of the infection within the affected tissues.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
Commonly observed effects following the administration of clindamycin include localized digestive changes such as vomiting, diarrhea or a temporary decrease in appetite. Some pets may exhibit behavioral shifts including lethargy. In some cases, loose stools may contain blood, which is an observational sign that warrants immediate clinical review. Owners should monitor their pet for any unusual digestive distress or persistent changes in eating habits and contact their veterinarian promptly with any concerns. This medication is typically used with extra caution or avoided in patients with known severe hepatic or renal impairment, as these organs are primary sites for the metabolism and clearance of the medication. It is also carefully evaluated in pets with pre-existing gastrointestinal disease. Significant interactions can occur if clindamycin is administered concurrently with neuromuscular blocking agents or specific other antibiotics that may interfere with its mechanism. Your veterinarian is the right person to provide guidance on the necessary duration of use and the proper administration schedule to ensure the management approach remains suitable for your pet's recovery.
Yes. Clindamycin is a prescription antibiotic and can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all veterinarian-client-patient relationships before any medication is prepared or shipped.
Yes. While clindamycin is available in various commercial capsule and liquid formats, Mixlab specializes in compounding the active ingredient into customized strengths and flavored dosage forms—such as flavored oral liquids or chewable may be considered in cases of—to suit the specific needs of dogs and cats. The decision between a commercial and compounded product rests with the prescribing veterinarian.
Veterinarians often discuss clindamycin for dental challenges because it has activity against anaerobic bacteria, which are common in the mouth. It is also valued for its ability to penetrate into deep tissues and bone where dental infections often reside.
Commercial liquid clindamycin is known for its localized bitter taste, which can make administration difficult for some owners. Your veterinarian may recommend a flavored compounded version to help manage your pet's acceptance of the medication during the recovery process.
